281 related articles for article (PubMed ID: 24316979)
21. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway.
Wang L; Zhao Y; Xiong Y; Wang W; Fei Y; Tan C; Liang Z
Exp Cell Res; 2018 Jan; 362(2):424-435. PubMed ID: 29246726
[TBL] [Abstract][Full Text] [Related]
22. The significance of CUX1 and chromosome 7 in myeloid malignancies.
Jotte MRM; McNerney ME
Curr Opin Hematol; 2022 Mar; 29(2):92-102. PubMed ID: 35084368
[TBL] [Abstract][Full Text] [Related]
23. The homeodomain protein Cux1 interacts with Grg4 to repress p27 kip1 expression during kidney development.
Sharma M; Brantley JG; Vassmer D; Chaturvedi G; Baas J; Vanden Heuvel GB
Gene; 2009 Jun; 439(1-2):87-94. PubMed ID: 19332113
[TBL] [Abstract][Full Text] [Related]
24. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
[TBL] [Abstract][Full Text] [Related]
25. Biochemical characterization of the mammalian Cux2 protein.
Gingras H; Cases O; Krasilnikova M; Bérubé G; Nepveu A
Gene; 2005 Jan; 344():273-85. PubMed ID: 15656993
[TBL] [Abstract][Full Text] [Related]
26. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling.
Stratigopoulos G; LeDuc CA; Cremona ML; Chung WK; Leibel RL
J Biol Chem; 2011 Jan; 286(3):2155-70. PubMed ID: 21037323
[TBL] [Abstract][Full Text] [Related]
27. CUX1 regulates human hematopoietic stem cell chromatin accessibility via the BAF complex.
Liu W; Kurkewich JL; Stoddart A; Khan S; Anandan D; Gaubil AN; Wolfgeher DJ; Jueng L; Kron SJ; McNerney ME
Cell Rep; 2024 May; 43(5):114227. PubMed ID: 38735044
[TBL] [Abstract][Full Text] [Related]
28. Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.
Sansregret L; Gallo D; Santaguida M; Leduy L; Harada R; Nepveu A
J Biol Chem; 2010 Oct; 285(43):32834-32843. PubMed ID: 20729212
[TBL] [Abstract][Full Text] [Related]
29. CUX1 transcription factor is required for optimal ATM/ATR-mediated responses to DNA damage.
Vadnais C; Davoudi S; Afshin M; Harada R; Dudley R; Clermont PL; Drobetsky E; Nepveu A
Nucleic Acids Res; 2012 May; 40(10):4483-95. PubMed ID: 22319212
[TBL] [Abstract][Full Text] [Related]
30. Upregulated Expression of CUX1 Correlates with Poor Prognosis in Glioma Patients: a Bioinformatic Analysis.
Wu X; Feng F; Yang C; Zhang M; Cheng Y; Zhao Y; Wang Y; Che F; Zhang J; Heng X
J Mol Neurosci; 2019 Dec; 69(4):527-537. PubMed ID: 31377983
[TBL] [Abstract][Full Text] [Related]
31. Long-range transcriptional regulation by the p110 CUX1 homeodomain protein on the ENCODE array.
Vadnais C; Awan AA; Harada R; Clermont PL; Leduy L; Bérubé G; Nepveu A
BMC Genomics; 2013 Apr; 14():258. PubMed ID: 23590133
[TBL] [Abstract][Full Text] [Related]
32. Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms.
Imgruet MK; Lutze J; An N; Hu B; Khan S; Kurkewich J; Martinez TC; Wolfgeher D; Gurbuxani SK; Kron SJ; McNerney ME
Blood; 2021 Sep; 138(9):790-805. PubMed ID: 34473231
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells.
An N; Khan S; Imgruet MK; Jueng L; Gurbuxani S; McNerney ME
Oncogene; 2023 Mar; 42(12):881-893. PubMed ID: 36725889
[TBL] [Abstract][Full Text] [Related]
34. Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.
Alcalay NI; Sharma M; Vassmer D; Chapman B; Paul B; Zhou J; Brantley JG; Wallace DP; Maser RL; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1725-34. PubMed ID: 18829740
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
[TBL] [Abstract][Full Text] [Related]
36. CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.
Kaur S; Ramdzan ZM; Guiot MC; Li L; Leduy L; Ramotar D; Sabri S; Abdulkarim B; Nepveu A
Neuro Oncol; 2018 Mar; 20(4):484-493. PubMed ID: 29036362
[TBL] [Abstract][Full Text] [Related]
37. Genomic studies controvert the existence of the CUX1 p75 isoform.
Krishnan M; Senagolage MD; Baeten JT; Wolfgeher DJ; Khan S; Kron SJ; McNerney ME
Sci Rep; 2022 Jan; 12(1):151. PubMed ID: 34997000
[TBL] [Abstract][Full Text] [Related]
38. Transcription of the human EAP1 gene is regulated by upstream components of a puberty-controlling Tumor Suppressor Gene network.
Mueller JK; Koch I; Lomniczi A; Loche A; Rulfs T; Castellano JM; Kiess W; Ojeda S; Heger S
Mol Cell Endocrinol; 2012 Apr; 351(2):184-98. PubMed ID: 22209758
[TBL] [Abstract][Full Text] [Related]
39. High doses of TGF-β potently suppress type I collagen via the transcription factor CUX1.
Fragiadaki M; Ikeda T; Witherden A; Mason RM; Abraham D; Bou-Gharios G
Mol Biol Cell; 2011 Jun; 22(11):1836-44. PubMed ID: 21471005
[TBL] [Abstract][Full Text] [Related]
40. In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.
Karreth FA; Tay Y; Perna D; Ala U; Tan SM; Rust AG; DeNicola G; Webster KA; Weiss D; Perez-Mancera PA; Krauthammer M; Halaban R; Provero P; Adams DJ; Tuveson DA; Pandolfi PP
Cell; 2011 Oct; 147(2):382-95. PubMed ID: 22000016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
